I obtained my Doctoral degrees in Medicine from Nanjing Medical University in 2018. From 2018 to 2022, I was a postdoctoral fellow at Nanjing Drum Tower Hospital. Since July 2022, I have been a full-time professor and doctoral supervisor at the First Affiliated Hospital of Anhui Medical University. My lab focus on the molecular mechanism and potential clinical significance of genetic and epigenetic modifications in the development of common gastrointestinal tumors. I have been awarded the titles of Outstanding Young Talents and Scholars in Anhui Province (2023), "New Star of Fuyuan Technology" at Anhui Medical University (2023), recipient of the Excellent Youth Fund from the Education Department of Anhui Province (2022), and PI of the Anhui Province Liver Cancer Immune Microenvironment Research and Treatment Innovation Research Team (2022). My main research direction is RNA epigenetics and digestive tract tumors. In the past five years, I have published as the corresponding/first author (including co authors) in journals such as Oncogene (2024), Cancer Lett (2024), Gut (2023, 2020), Nat Cancer (2022), Adv Sci (2022), J Hematol Oncol (2020), etc. Among them, there is one highly cited ESI paper, with a maximum citation of over 610 times per paper and an H-index of 18. I have hosted two National Natural Science Foundation projects, one Excellent Youth Fund project of Anhui Provincial Department of Education, one research fund of Anhui Institute of Translational Medicine, and one general and special funding (station) fund of China Postdoctoral Science Foundation. One each, one Nanjing Health Science and Technology Development Special Fund for Outstanding Young Talents Fund, etc. Currently a member of the Chinese Society of Cell Biology and the Chinese Society of Toxicology; Expert evaluation letter from the Medical Department of the National Natural Science Foundation of China; Serving as a Review Editor for Frontiers in Pharmacology and Frontiers in Oncology journals; Invited as a reviewer for SCI journals such as Journal of Hematology&Oncology, Journal of Gastroenterology, iSCIENCE, BBA Mol Basis Dis, etc. I have reviewed more than 50 times for relevant journals. Focus on the molecular mechanism and potential clinical significance of genetic and epigenetic modifications in the development of common gastrointestinal tumors. My professional field is scientific research, and I possess key skills in active listening, effective communication, leadership, mentoring, and problem-solving. I excel at understanding team needs, clearly expressing research ideas, inspiring innovation, guiding team members, managing projects efficiently, and calmly addressing challenges. These skills enable me to excel in my research work and drive project success. My hobbies include reading, hiking, and playing chess, which expand my knowledge, keep me fit, and sharpen my strategic thinking.